Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.78% vs -6.98% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -3,30,400.00% vs 99.76% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 112.41% vs -437.04% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 87.50% vs 14.29% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Myriad Genetics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.78% vs -6.98% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.76% vs 15.26% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -3,30,400.00% vs 99.76% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -800.54% vs 68.39% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 112.41% vs -437.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 118.56% vs 51.50% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 87.50% vs 14.29% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 87.50% vs 60.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






